The Human Protein Atlas warns that GPX2 antibodies used in that analysis appear to exhibit off-target binding (https://www.proteinatlas.org/, as of 30 May 2024) and declares that, generally, the protein was not detected in GBM, while in the detailed comments suggesting that Purkinje cells and not glia show some GPX2 staining in normal samples. The gene discussed is GPX2; the disease is glioblastoma.